Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05967897 · ClinicalTrials.gov registry record · NA
Enhancing the Benefits of Blueberry Polyphenols With Protein
A NA study, sponsored by Colorado State University.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT05967897: Completed NA study, sponsored by Colorado State University.
NCT05967897 is a NA study that has completed, run by Colorado State University. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05967897, a NA study, has completed, sponsored by Colorado State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this randomized crossover trial is determine whether acute consumption of blueberries with different proteins from plants (hemp or pea) or dairy (whey) impact the absorption of blueberry phytochemicals, which could impact the health benefits of blueberries. A secondary purpose is to understand the role that the gut microbiome may play, as well as the impact on urine polyphenol metabolites and potential implications for cardiometabolic health. Researchers will compare four arms: 1) Blueberries; 2) Blueberries + whey protein; 3) Blueberries + pea protein; and 4) Blueberries + hemp protein.
Primary Outcome
Plasma polyphenol metabolite analysis using mass spectrometry
Interventions
- DIETARY_SUPPLEMENT Blueberries
- DIETARY_SUPPLEMENT Blueberries and Whey Protein
- DIETARY_SUPPLEMENT Blueberries and Pea Protein
- DIETARY_SUPPLEMENT Blueberries and Hemp Protein
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2023-03-09 |
| Est. Completion | 2024-06-01 |
| Phase | NA |
What the finished NCT05967897 record still lists
NCT05967897 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Blueberries is the first listed.
NCT05967897 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05967897 about?
NCT05967897 is a clinical study titled "Enhancing the Benefits of Blueberry Polyphenols With Protein". The purpose of this randomized crossover trial is determine whether acute consumption of blueberries with different proteins from plants (hemp or pea) or dairy (whey) impact the absorption of blueberry phytochemicals, which could impact the health benefits of blueberries. A secondary purpose is to u...
What is the current status of trial NCT05967897?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2023-03-09. Estimated completion is 2024-06-01.
What interventions are being tested in trial NCT05967897?
The interventions under investigation include: Blueberries (DIETARY_SUPPLEMENT), Blueberries and Whey Protein (DIETARY_SUPPLEMENT), Blueberries and Pea Protein (DIETARY_SUPPLEMENT), Blueberries and Hemp Protein (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05967897?
This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05967897's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI